Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Adenosine deaminase, RNA-specific, B1 pseudogene is a non-functional segment of DNA on chromosome X that is homologous to the ADARB1 gene encoding double-stranded RNA-specific editase 1, but contains sequence changes that prevent it from coding a functional protein. Like other pseudogenes, it may be transcribed and could function in gene regulation, such as acting as a microRNA decoy or generating regulatory RNAs through the RNA interference pathway, although there is no direct evidence of a functional consequence for this specific pseudogene. Pseudogenes are generally considered "non-targets" for therapeutic intervention due to their lack of protein product.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Adenosine deaminase, RNA-specific, B1 pseudogene (ADARB1 pseudogene).